Addiction: a strong and harmful need to regularly have something (such as a drug) or engage in a specific behavior (such as gambling) due to an overwhelming biochemical drive, and which cannot be controlled by behavioral restraint.
ALT: alanine aminotransferase, a blood test that tells about liver function and is very sensitive for the amount of fat in the liver.
Amygdala: part of the stress-fear-memory pathway. This walnut-sized area of the brain generates the feelings of fear and stress, which tells the hypothalamus to tell the adrenal glands to make extra cortisol.
Anandamide: a naturally occurring neurotransmitter that binds to the CB1 endocannabinoid receptor and that reduces levels of anxiety.
Apoptosis: programmed cell death, in which proteins in the cell are activated to cause self-destruction.
Autonomic nervous system: that part of the nervous system that controls unconscious functions of the body. It consists of two parts: the sympathetic system controls heart rate, blood pressure, and temperature; while the parasympathetic system (the vagus nerve) controls eating, digestion, and absorption, slows the heart rate, and lowers blood pressure. The two together control energy balance.
Cortisol: the stress hormone released from the adrenal glands, which acutely mobilizes sugar for use but which chronically lays down visceral fat and also reduces serotonin-1a receptor number.
Depression: a mental condition characterized by feelings of severe despondency and dejection, inadequacy, and guilt, often accompanied by lack of energy and disturbance of appetite and sleep.
Developmental programming: alterations in brain or body functioning due to alterations in the environment that occur in the fetus prior to birth.
Dopamine: part of the reward pathway. A neurotransmitter that, when released, can acutely cause feelings of reward but, when released, chronically reduces the number of its receptors, leading to tolerance.
Dopamine receptor: the protein that binds dopamine to generate the reward signal and, when reduced in number, leads to tolerance.
Endocannabinoid: a neurotransmitter, such as anandamide, that binds to brain receptors and acts like marijuana, driving reward and reducing anxiety.
Endogenous opioid peptide (EOP): part of the reward pathway. A neurotransmitter made in the brain that binds to its receptor to signal the consummation of reward or euphoria.
Endogenous opioid peptide (EOP) receptor: part of the reward pathway. A protein that binds either opiates (e.g., heroin) or endogenous opioid peptides (e.g., beta-endorphin) to signal the consummation of reward or euphoria.
Epigenetics: modifications in DNA without changes in the DNA genetic sequence, usually occurring prior to birth.
Estrogen: female sex hormone, made either in the ovary or in fat tissue.
Excitotoxicity: the process of overstimulating a cell, leading to cell dysfunction or death.
Fructose: half of dietary sugar or high-fructose corn syrup. The molecule that makes sugar taste sweet causes the reward system to activate, and is the addictive component.
Glucose: half of dietary sugar or high-fructose corn syrup. Also the molecule found in starch, the molecule that every cell on the planet burns to liberate energy.
Hippocampus: part of the stress-fear-memory pathway. The part of the brain where memories are housed and that exerts influences on the amygdala and prefrontal cortex.
Hypothalamus: part of the stress-fear-memory pathway. The area at the base of the brain that controls various hormone systems of the body, particularly cortisol.
Insulin resistance: the state where insulin signaling is reduced, requiring the beta-cells of the pancreas to make more insulin, which drives both obesity and chronic disease.
Insulin secretion: the process of insulin release in response to both rising blood glucose and the firing of the vagus nerve.
Insulin: a hormone made in the pancreas that tells fat cells to store energy and interferes with the leptin signal to increase food intake.
Leptin resistance: the state where the leptin signal is dampened, leading to the hypothalamus interpreting starvation.
Leptin: a hormone released from fat cells that travels in the bloodstream to the hypothalamus to report on peripheral energy stores.
Major depressive disorder (MDD): a mental disorder characterized by at least two weeks of low mood, self-esteem, loss of interest in normally enjoyable activities, low energy, and pain without a clear cause, often needing medical treatment.
Metabolic syndrome: a cluster of chronic metabolic diseases characterized by energy overload of cells.
Micronutrient: vitamins or minerals found in real food, usually isolated with the fiber fraction.
Mitochondria: subcellular organelles specialized to burn either fat or carbohydrate for energy.
Neurotransmitter: a chemical in the brain made in one nerve cell, which, when released, causes other nerve cells to fire.
Necrosis: cell death due to exposure to a toxin or lack of blood or oxygen.
Nucleus accumbens (NA): the area of the brain that receives the dopamine signal and interprets the feeling as reward.
Obesity: excess body fat deposition.
Omega-3 fatty acids: a fatty acid found in wild fish and flax that is an important component of neuronal membranes and that reduces inflammation.
Phenylalanine: a dietary amino acid that can be converted into dopamine.
Prefrontal cortex (PFC): part of the stress-fear-memory pathway. The part of the brain, located in the front (above the eyes), that inhibits impulsive and socially unacceptable and potentially dangerous behaviors and actions.
Peptide YY(3-36): a hormone made by the small intestine in response to food that signals satiety to the hypothalamus.
Satiety: the feeling of fullness that stops further eating.
Serotonin: part of the contentment pathway. A neurotransmitter that, when it binds to its -1a receptor on neurons, transmits feelings of contentment; and, when it binds to its -2a receptor, evokes the “mystical experience.”
Serotonin-1a receptor: part of the contentment pathway. A protein on the surface of neurons that, when it binds serotonin, reduces neurotransmission, which leads to feelings of contentment.
Serotonin-2a receptor: a protein on the surface of neurons that, when it binds serotonin, evokes the “mystical experience.”
Stress: an uncomfortable state of mental or emotional strain or tension resulting from adverse or demanding circumstances. Accompanied by neural output from the amygdala, which tells the hypothalamus to signal the adrenal glands to make the hormone cortisol.
Subcutaneous fat: the fat outside of the abdomen, which is a storehouse of extra energy but which does not signify an increased risk for metabolic syndrome.
Sympathetic nervous system: the part of the autonomic nervous system that raises heart rate, increases blood pressure, and burns energy.
Tetrahydrocannabinol: the active substance in marijuana that binds to the CB1 endocannabinoid receptor to reduce levels of anxiety.
Tolerance: the state where the signal for reward is dampened and can only be generated by consuming more substrate (e.g., sugar) or engaging in more behaviors (e.g., gambling).
Transcription factor: a protein in cells that turns on genes to make the cell change its function.
Tryptophan: a dietary amino acid that is converted into serotonin.
Type 2 diabetes: a disease of high blood sugar due to defective insulin action on tissues.
Tyrosine: an amino acid (which can be consumed, or derived from phenylalanine) that can be converted into dopamine.
Vagus nerve: part of the autonomic nervous system that promotes food digestion, absorption, and energy storage, and slows heart rate.
Ventral tegmental area (VTA): part of the reward pathway. The area of the brain that sends the dopamine signal of signifying reward to the nucleus accumbens.
Visceral fat: the fat around the organs in the abdomen, which is a risk factor for diabetes, heart disease, and stroke, and a marker for metabolic syndrome.